Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title: Editorial [Hot topic: Newly Recognized Actions of Vitamin D3 (Guest Editor: Ilka Nemere)]
Volume: 9 Issue: 3
Author(s): Ilka Nemere
Affiliation:
Export Options
About this article
Cite this article as:
Nemere Ilka, Editorial [Hot topic: Newly Recognized Actions of Vitamin D3 (Guest Editor: Ilka Nemere)], Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2009; 9 (3) . https://dx.doi.org/10.2174/187152209789760468
DOI https://dx.doi.org/10.2174/187152209789760468 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
11
Related Articles
-
Oxidative and Non-Oxidative Metabolomics of Ethanol
Current Drug Metabolism MR Imaging Findings of Uterine Cervical Carcinoma
Current Medical Imaging Advances in Nanocarriers for Anticancer Drugs Delivery
Current Medicinal Chemistry Exploring and Exploiting Biologically Relevant Chemical Space
Current Drug Targets Emerging Concepts in the Analysis of Mitochondrial Genome Instability
Current Genomics Application of In Vivo Electroporation to Cancer Gene Therapy
Current Gene Therapy Anti-Cancer Drug Design Using Natural and Synthetic Pharmacophores
Current Organic Chemistry Efficient Gene Transfer to Rat Fetal Osteoblastic Cells by Synthetic Peptide Vector System
Protein & Peptide Letters What is the Current Role of Immunotherapy for Colon Cancer?
Reviews on Recent Clinical Trials Solid Lipid Nanoparticles Containing Nimesulide: Preparation, Characterization and Cytotoxicity Studies
Current Nanoscience EGFR(S) Inhibitors in the Treatment of Gastro-Intestinal Cancers: Whats New?
Current Drug Targets Can γH2AX be Used to Personalise Cancer Treatment?
Current Molecular Medicine Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction
Anti-Cancer Agents in Medicinal Chemistry Resveratrol Targets in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Chemosensitization and Immunosensitization of Resistant Cancer Cells to Apoptosis and Inhibition of Metastasis by the Specific NF-κB Inhibitor DHMEQ
Current Pharmaceutical Design Editorial (Mini Thematic Issue: Immunotherapy – A Pivotal Mechanism in the Fight of Cancer)
Reviews on Recent Clinical Trials Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance
Current Drug Targets Cytotoxicity of Novel Sulfanilamides Towards Sensitive and Multidrugresistant Leukemia Cells
Current Medicinal Chemistry Tachykinins and their Receptors in Human Malignancies
Current Drug Targets Topical Ingenol Mebutate: A New Treatment Modality for Multiple Actinic Keratoses and Field Cancerization
Anti-Cancer Agents in Medicinal Chemistry